These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11176224)

  • 21. Is plasma homocysteine a modifiable risk factor for stroke?
    Hankey GJ
    Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis.
    Zeng R; Xu CH; Xu YN; Wang YL; Wang M
    Public Health Nutr; 2015 Jun; 18(8):1514-21. PubMed ID: 25323814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocysteine and cerebral stroke in developing countries.
    Christopher R; Nagaraja D; Shankar SK
    Curr Med Chem; 2007; 14(22):2393-401. PubMed ID: 17896987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine and risk of cardiovascular disease among postmenopausal women.
    Ridker PM; Manson JE; Buring JE; Shih J; Matias M; Hennekens CH
    JAMA; 1999 May; 281(19):1817-21. PubMed ID: 10340369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma homocysteine and ischemic stroke patients in Thailand.
    Tantirittisak T; Sura T; Moleerergpoom W; Hanchaipiboolkul S
    J Med Assoc Thai; 2007 Jun; 90(6):1183-7. PubMed ID: 17624215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA.
    Bos MJ; van Goor ML; Koudstaal PJ; Dippel DW
    J Neurol; 2005 Mar; 252(3):332-7. PubMed ID: 15739046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration
    Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.
    Towfighi A; Arshi B; Markovic D; Ovbiagele B
    Cerebrovasc Dis; 2014; 37(4):263-7. PubMed ID: 24751920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors.
    Brattström L; Lindgren A; Israelsson B; Malinow MR; Norrving B; Upson B; Hamfelt A
    Eur J Clin Invest; 1992 Mar; 22(3):214-21. PubMed ID: 1582447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.
    Scott TM; Rogers G; Weiner DE; Livingston K; Selhub J; Jacques PF; Rosenberg IH; Troen AM
    J Prev Alzheimers Dis; 2017; 4(3):174-182. PubMed ID: 29182708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
    Homocysteine Studies Collaboration
    JAMA; 2002 Oct 23-30; 288(16):2015-22. PubMed ID: 12387654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The case for mild hyperhomocysteinaemia as a risk factor.
    Boers GH
    J Inherit Metab Dis; 1997 Jun; 20(2):301-6. PubMed ID: 9211202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of C-Reactive Protein and Homocysteine in Large-Artery Atherosclerotic Stroke: a Prospective Observational Study.
    Ye Z; Zhang Z; Zhang H; Hao Y; Zhang J; Liu W; Xu G; Liu X
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):618-626. PubMed ID: 27979431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic stroke.
    Chen M; Wu B; Ye X; Zhou Z; Yue X; Wang Q; Wang W; Jiang Y; Lian X; Chen Z; Xu G; Liu X
    J Clin Neurosci; 2011 Nov; 18(11):1454-7. PubMed ID: 21917464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can lowering homocysteine levels reduce the incidence of stroke?
    Sarkar PK; Lambert L
    J Clin Pharm Ther; 1999 Oct; 24(5):331-8. PubMed ID: 10583695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated plasma homocysteine upon ischemic stroke is associated with increased long-term mortality in women.
    Markaki I; Klironomos S; Kostulas K; Sjostrand C
    PLoS One; 2017; 12(8):e0183571. PubMed ID: 28846725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Homocysteine and Prognosis of Acute Ischemic Stroke: a Gender-Specific Analysis From CATIS Randomized Clinical Trial.
    Zhong C; Xu T; Xu T; Peng Y; Wang A; Wang J; Peng H; Li Q; Geng D; Zhang D; Zhang Y; Zhang Y; Gao X; He J;
    Mol Neurobiol; 2017 Apr; 54(3):2022-2030. PubMed ID: 26910818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine, renal function, and risk of cardiovascular disease.
    Clarke R; Lewington S; Landray M
    Kidney Int Suppl; 2003 May; (84):S131-3. PubMed ID: 12694328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine-lowering therapy: a role in stroke prevention?
    Spence JD
    Lancet Neurol; 2007 Sep; 6(9):830-8. PubMed ID: 17706567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma homocysteine levels in patients with ischemic cerebral infarction].
    Vila N; Deulofeu R; Chamorro A; Piera C
    Med Clin (Barc); 1998 May; 110(16):605-8. PubMed ID: 9656197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.